Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Related stories
SpaceX is moments away from monumental Starship launch
Nvidia launches record $150bn share buyback
Nvidia makes a statement with historic $150 billion buyback announcement
A pullback is brewing, say these strategists who have examined every drawdown since 1956
Why Europe’s centre will hold
What is the AI capex breakeven rate?